Navigation Links
Younger Adults Increasingly Treated for Heart Disease-related Conditions
Date:10/30/2007

Increase in use of cholesterol and hypertension medications largest among

people ages 20 to 44 Drop in the age of women using heart disease medications greater than men

FRANKLIN LAKES, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Heart disease, high blood pressure and hardening of the arteries - conditions that are usually associated with the senior population - are creeping into young adulthood. According to new research conducted by Medco Health Solutions, Inc. (NYSE: MHS), prescription drug use by younger adults for heart disease- related conditions is increasing at a rapid rate, far outpacing older adults and offering a glimpse into the forthcoming clinical and financial challenges facing the nation's health care system.

The analysis shows that between 2001 and 2006, the number of 20-44 year olds taking prescription medications to treat high cholesterol increased 68 percent, and use of antihypertensives jumped 21 percent.

Based on this new analysis, the estimated number of 20-44 year olds nationwide on lipid-lowering drugs surged from 2.5 million in 2001 to 4.2 million in 2006, while the number of people of that age taking antihypertensives spiked from 7 million to 8.5 million in the six-year period.

"This may be both a good news, bad news story," said Dr. Robert Epstein, Medco's chief medical officer. "The good news is that younger patients are taking medications that control conditions that, if left untreated, could lead to heart attacks and strokes - indicating that physicians are screening patients more regularly and treating these precursors more aggressively than in the past. The bad news is that these conditions are showing up in patients at younger ages, which
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia
3. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
4. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
5. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
6. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
7. FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications
8. New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
9. Eighty-one Percent of U.S. Adults say that Birth Control Pills and Procedures Should Be Covered by Health Insurance
10. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
11. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4Nations Oldest Taxpayer Group Criticizes Committee Vote for Baucus Health Bill Hidden Tax Increases 59401 1Nations Oldest Taxpayer Group Criticizes Committee Vote for Baucus Health Bill Hidden Tax Increases 59401 2Fraunhofer CSE Opens First Laboratory in Cambridge MA 14456 1Fraunhofer CSE Opens First Laboratory in Cambridge MA 14456 2Fraunhofer CSE Opens First Laboratory in Cambridge MA 14456 3Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations 14454 1Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations 14454 2Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations 14454 3Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations 14454 4Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations 14454 5